Latest Disclosure Policy News

AGL Energy has clarified that its FY25 underlying earnings aligned with market forecasts and published guidance, dismissing any material surprises in its financial results. The company also addressed statutory profit volatility and confirmed compliance with ASX disclosure rules.

Weebit Nano has responded to an ASX price query following a sharp rise in its share price and trading volume, attributing the activity to a misleading article on the Motley Fool website. The company denies any undisclosed price-sensitive information and confirms full compliance with ASX disclosure rules.

Bayan Mining and Minerals Limited has responded to ASX queries about recent unusual trading activity, confirming no undisclosed material information. The company attributes the price and volume surge to market speculation and news from nearby projects in the rare earth elements sector.

Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

Sequoia Financial Group has responded to an ASX price query, denying any undisclosed material information behind recent trading fluctuations and reaffirming compliance with listing rules amid ongoing ASIC investigations.

Elsight Limited has responded to ASX concerns over a premature media report on its $60 million capital raise, denying any unauthorized disclosures and reaffirming its compliance with continuous disclosure rules.

Raptis Group Limited has confirmed that director James Raptis will resign effective 30 September 2025, affirming the company’s compliance with ASX continuous disclosure rules.

Advance ZincTek Limited (ASX, ANO) has responded to an ASX price query following a sharp increase in its share price and trading volume, confirming no undisclosed material information and reaffirming compliance with continuous disclosure rules.

Arika Resources has responded to an ASX price query, confirming no undisclosed information behind recent share price movements and highlighting its active drilling program and recent $5 million capital raise.

Alterity Therapeutics has responded to an ASX inquiry about its recent share price and volume spike, confirming no undisclosed information but highlighting imminent clinical data releases and investor roadshows as possible drivers.

DY6 Metals has addressed an ASX price query by confirming confidential negotiations for acquiring additional mining licenses in Cameroon, explaining recent share price movements and ensuring compliance with continuous disclosure rules.